Megaloblastic anaemia results from a deficiency of:
(i) Vitamin B12
(ii) Iron
(iii) Vitamic C
(iv) Folic Acid Select the correct answer using the choices given below :

Question

Megaloblastic anaemia results from a deficiency of: 
(i) Vitamin B12 
(ii) Iron 
(iii) Vitamic C 
(iv) Folic Acid Select the correct answer using the choices given below :

Accepted Answer

The correct option is 3 (i & iv):

Megaloblastic anaemia is a specific type of macrocytic anaemia characterized by the presence of abnormally large, immature red blood cell precursors, known as megaloblasts, in the bone marrow. The underlying cause of this condition is a fundamental failure in DNA synthesis, which is essential for cell division and proper maturation of the cell nucleus. Both Vitamin B12 (cobalamin) and Folic Acid (folate) are crucial B vitamins required as co-factors in the metabolic pathways that synthesize the building blocks of DNA. Folic Acid is directly involved in the creation of purines and thymidines, and Vitamin B12 is necessary to convert folate into its metabolically active form. A deficiency in either one of these essential nutrients cripples the body's ability to produce new, healthy DNA. This impairment prevents the red blood cell precursors in the bone marrow from dividing and maturing correctly, resulting in oversized, dysfunctional red blood cells. Therefore, a deficiency in (i) Vitamin B12 and/or (iv) Folic Acid directly leads to the characteristic cellular abnormality seen in megaloblastic anaemia.

The incorrect option is 1 (i, ii & iv):

This option is incorrect because it includes (ii) Iron. Iron deficiency is the most common nutritional cause of anaemia globally, but it results in a condition called *iron deficiency anaemia*, not megaloblastic anaemia. Iron is the core mineral component of the protein hemoglobin, which is responsible for carrying oxygen. When iron is deficient, the red blood cells produced are typically *microcytic* (abnormally small) and *hypochromic* (abnormally pale) due to insufficient hemoglobin content. This is a completely different mechanism—a failure in hemoglobin synthesis—compared to the failure in DNA synthesis that defines the megaloblastic type. Thus, while (i) and (iv) are correct, the inclusion of (ii) makes the combination inaccurate for diagnosing this specific disorder.

The incorrect option is 2 (ii & iii):

This option is incorrect because it suggests that (ii) Iron and (iii) Vitamin C deficiencies are the causes of megaloblastic anaemia. As already established, iron deficiency causes microcytic anaemia. Furthermore, a deficiency in Vitamin C (ascorbic acid) is primarily linked to Scurvy, a disorder affecting collagen and connective tissue. While Vitamin C does play important roles in the body, such as enhancing the absorption of non-heme iron and acting as an antioxidant, it is not directly required as a cofactor in the critical DNA synthesis pathway involving Vitamin B12 and Folic Acid. Therefore, a primary deficiency of Vitamin C does not result in the distinct large-celled pathology of megaloblastic anaemia, and the combination in this option is incorrect.

The incorrect option is 4 (i & ii):

This option correctly identifies (i) Vitamin B12 but incorrectly includes (ii) Iron. Understanding the difference between the two types of anaemia is crucial for correct clinical diagnosis and treatment. Megaloblastic anaemia is characterized by the failure of the nuclear material to mature, which is a direct consequence of Vitamin B12 or Folic Acid deficiency leading to impaired DNA synthesis. In contrast, iron deficiency affects the cell's size and colour due to limited hemoglobin production, leading to microcytic anaemia. Confusing these two distinct types of anaemia, which are differentiated by their underlying metabolic cause and the appearance of the red blood cells on a blood smear, is a common error, but scientifically incorrect.